Navigation Links
InterMune to Present at Goldman Sachs Healthcare and Needham & Co. Biotechnology and Medical Technology Conferences
Date:6/6/2008

BRISBANE, Calif., June 6 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that John Hodgman, Senior Vice President and Chief Financial Officer of InterMune, will present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference in Dana Point, Calif. on June 10, 2008 at 8:05 a.m. PDT (11:05 a.m. EDT). Mr. Hodgman will also present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference in New York on June 12, 2008 at 9:30 a.m. EDT.

To access a live audio webcast of either presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at http://www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentations in order to register or download any necessary software.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone as a possible therapeutic candidate for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating a new target in hepatology. For additional information about InterMune and its R&D pipeline, please visit http://www.intermune.com.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. InterMune to Present at Citigroup Healthcare Conference
2. InterMune to Present at Bank of America Health Care Conference
3. InterMune to Present at Deutsche Bank Health Care Conference
4. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
5. Evotec Expands Collaboration With InterMune
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
8. InterMune Announces Closing of Public Offering of Common Stock
9. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
10. InterMune Announces Proposed Public Offering of Common Stock
11. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... ... October 09, 2019 , ... ... Montgomery County middle school and high school students have improved neuro-cognitive executive skills ... techniques and physical fitness, and apply lifelong social/interpersonal, leadership, problem-solving and coping skills, ...
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia Corporation, the global ... today announces that the U.S. Food and Drug Administration (FDA) has granted the ... temporary relief of chronic neck and shoulder pain of musculoskeletal origin. , Erchonia ...
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked the official ... enabling clinical program outsourcing success by cultivating radical improvements in leadership, staff, and ... executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise in the ...
(Date:10/3/2019)... ... , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials New ... M.D., Ph.D., discussed important design factors that currently limit the success of early stage ... of clinical trials, in his talk Dr. Sherley focused on the highly ...
Breaking Biology Technology:
(Date:10/8/2019)... ... October 07, 2019 , ... Imaging data sets are generated ... optical projection tomography, optical coherence tomography, echocardiogram, light sheet microscopy, MRI and X-ray ... inhouse, a lot of research groups struggle with transforming these large and sometimes ...
(Date:10/4/2019)... ... 2019 , ... Representatives with MyBioGate ( https://events.mybiogate.com/ ) announced ... Hamburg Rothenbaumchaussee in Hamburg. , “To better connect Chinese companies and European markets, ... of Operations and spokesperson for MyBioGate. , Guo went on to highlight that ...
(Date:10/3/2019)... ... 01, 2019 , ... The CHEM+POUR Bag was ... and to be a more environmentally sustainable evolution to plastic or glass bottles. ... and feedback from the original version we launched in September 2015,” said Aaron ...
Breaking Biology News(10 mins):